The president signed it. It is now a real law.
SUPPORT for Patients and Communities Reauthorization Act of 2025 This act reauthorizes and revises programs and activities relating to addressing substance use disorders, overdoses, and mental health. (For additional information on each section of this act, see CRS Report R48864 .) TITLE I--PREVENTION (Sec. 101) This section reauthorizes through FY2030 Centers for Disease Control and Prevention (CDC) programs that provide information, grants, and technical assistance relating to studying and preventing prenatal and postnatal substance use disorders. (Sec. 102) This section reauthorizes through FY2030 CDC programs that carry out and provide grants for surveillance, treatment, and education relating to infections associated with illicit drug use. (Sec. 103) This section reauthorizes through FY2030 and expands CDC programs that carry out activities and provide grants relating to monitoring drug use and overdoses (e.g., supporting state prescription drug monitoring programs), preventing and responding to substance use disorders, and raising awareness regarding opioids and other substances. The section authorizes additional activities, including wastewater surveillance and collecting data on risk factors associated with overdoses. (Sec. 104) This section reestablishes, expands, and provides statutory authority for Department of Health and Human Services (HHS) activities addressing fetal alcohol spectrum disorders (i.e., conditions caused by prenatal alcohol exposure), including carrying out and providing grants for research, education and public awareness, and intervention and support services for affected individuals. (Sec. 105) This section specifies that, in providing grants to support state prescription drug monitoring programs, the CDC is not authorized to require states to use specific vendors or interoperability systems other than to align with general, consensus-based standards for interoperability. (Sec. 106) This section reauthorizes thro